Stifel Nicolaus initiated coverage on Applied Genetic Technologies with a new price target
$AGTC
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Stifel Nicolaus initiated coverage of Applied Genetic Technologies with a rating of Buy and set a new price target of $14.00